| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/28/2002 | CA2420140A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420101A1 Kidney-specific protein |
| 02/28/2002 | CA2420087A1 Cripto tumour polypeptide |
| 02/28/2002 | CA2420071A1 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | CA2420054A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | CA2420036A1 Human 7tm proteins and polynucleotides encoding the same |
| 02/28/2002 | CA2419981A1 Coaster, a human coactivator of steroid receptors |
| 02/28/2002 | CA2419961A1 Methods and compositions for directed molecular evolution using dna-end modification |
| 02/28/2002 | CA2419919A1 Novel imidazoline receptor homologs |
| 02/28/2002 | CA2419915A1 New sequences |
| 02/28/2002 | CA2419908A1 High throughput method and kit |
| 02/28/2002 | CA2419901A1 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
| 02/28/2002 | CA2419872A1 Identification of a human n-terminal acetyltransferase gene |
| 02/28/2002 | CA2419810A1 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | CA2419646A1 Reduction of transmission of transgenes in plants |
| 02/28/2002 | CA2419454A1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | CA2419284A1 Prna chimera |
| 02/28/2002 | CA2419029A1 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | CA2418461A1 Method and compositions for promoting osteogenesis |
| 02/28/2002 | CA2418300A1 A novel aminopeptidase produced from aspergillus niger |
| 02/28/2002 | CA2418127A1 Transgenic plants with enhanced phenotypic properties and methods for producing them |
| 02/28/2002 | CA2418097A1 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature |
| 02/28/2002 | CA2418006A1 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | CA2417798A1 Method of amplifying nucleic acid |
| 02/28/2002 | CA2417787A1 Lipid metabolism enzymes |
| 02/28/2002 | CA2417186A1 Microtubule-associated proteins and tubulins |
| 02/28/2002 | CA2415182A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | CA2388061A1 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | CA2386913A1 Methods for external controls for nucleic acid amplification |
| 02/28/2002 | CA2356124A1 Anti-ige vaccines |
| 02/27/2002 | EP1182602A1 A system for the automatic analysis of images, such as DNA microarray images |
| 02/27/2002 | EP1182458A1 Method for detecting proteins under mutual interaction |
| 02/27/2002 | EP1182260A1 Process for producing amide compounds |
| 02/27/2002 | EP1182259A1 Pyruvate:NADP+ oxidoreductase and uses thereof |
| 02/27/2002 | EP1182258A1 Mutants of the factor VII activating protease and methods for their detection |
| 02/27/2002 | EP1182257A1 Nucleic acids encoding dihydroflavonol 4-reductase with altered specificity and uses thereof |
| 02/27/2002 | EP1182256A1 Pollinosis-associated gene 513 |
| 02/27/2002 | EP1182255A1 Genes involved in immune related responses observed with asthma |
| 02/27/2002 | EP1182254A1 Methods for separating, fractionating and analyzing gene of virus existing in water |
| 02/27/2002 | EP1182253A2 Method for improving the thermostability of proteins |
| 02/27/2002 | EP1182252A1 Methods for constructing dna library and support carrying dna library immobilized thereon |
| 02/27/2002 | EP1182250A2 Apparatus, systems and methods for microinjection of samples into amphibian oocytes |
| 02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
| 02/27/2002 | EP1182212A2 Ultraspiracle USP-protetin of Heliothis virescens |
| 02/27/2002 | EP1182211A1 Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity |
| 02/27/2002 | EP1182208A2 Composition for DNA transfection |
| 02/27/2002 | EP1182206A2 Stabilized oligonucleotids and the use thereof |
| 02/27/2002 | EP1181938A2 Rapamycin conjugates and antibodies |
| 02/27/2002 | EP1181559A2 System and method for filling a substrate with a liquid sample |
| 02/27/2002 | EP1181549A1 Protein-protein interactions |
| 02/27/2002 | EP1181524A2 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose |
| 02/27/2002 | EP1181395A2 Method for the synthesis of dna fragments |
| 02/27/2002 | EP1181392A1 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 02/27/2002 | EP1181391A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181389A1 Method of amplification of nucleic acids |
| 02/27/2002 | EP1181388A2 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181382A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 02/27/2002 | EP1181381A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 02/27/2002 | EP1181380A1 Methods for modulating water-use efficiency or productivity in a plant |
| 02/27/2002 | EP1181379A1 Method for reducing phytate in canola meal using genetic manipulation involving myo-inositol 1-phosphate synthase gene |
| 02/27/2002 | EP1181378A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
| 02/27/2002 | EP1181377A2 Protein conjugates, methods, vectors, proteins and dna for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 02/27/2002 | EP1181376A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophatidylinositol-modified carboxypeptidase g2 and a cell surface targeting signal peptide |
| 02/27/2002 | EP1181375A2 Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof |
| 02/27/2002 | EP1181374A1 Novel murine and human kinases |
| 02/27/2002 | EP1181373A1 Delta6-acetylenase and delta6-desaturase from ceratodon purpureus |
| 02/27/2002 | EP1181372A2 Viral expression vectors |
| 02/27/2002 | EP1181371A2 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 02/27/2002 | EP1181370A1 Methods and gene products for altering the shape of cells and organs in plants |
| 02/27/2002 | EP1181369A1 Four-helical bundle protein zsig81 |
| 02/27/2002 | EP1181368A1 Muteins of bilin-binding protein |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181366A1 Mammalian receptor proteins; related reagents and methods |
| 02/27/2002 | EP1181365A1 PrP-LIKE GENE |
| 02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
| 02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
| 02/27/2002 | EP1181362A1 Methods and reagents for inhibiting angiogenesis |
| 02/27/2002 | EP1181361A2 Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna |
| 02/27/2002 | EP1181360A1 Molecular switches |
| 02/27/2002 | EP1181359A1 Gene switches |
| 02/27/2002 | EP1181358A2 Methods and materials for generating sh3 domains with tailored binding properties |
| 02/27/2002 | EP1181353A1 Inducible packaging cell lines for lentivirus vectors |
| 02/27/2002 | EP1181352A1 Versican and epithelial-mesenchymal interaction |
| 02/27/2002 | EP1181351A1 Method of purifying heterologous proteins |
| 02/27/2002 | EP1181323A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 02/27/2002 | EP1181320A2 Somatic transgene immunization and related methods |
| 02/27/2002 | EP1181319A1 Dr4 antibodies and uses thereof |
| 02/27/2002 | EP1181318A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 02/27/2002 | EP1181317A1 An integrin heterodimer and an alpha subunit thereof |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181315A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 02/27/2002 | EP1181314A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations |
| 02/27/2002 | EP1181313A2 Peptides for vaccinating against human cmv |
| 02/27/2002 | EP1181312A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 02/27/2002 | EP1181306A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/27/2002 | EP1181305A1 Methods of modulating activity of prokaryotic ribosomes |
| 02/27/2002 | EP1181304A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin |
| 02/27/2002 | EP1181303A1 50 human secreted proteins |